This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of ...

Panelists discuss treatment considerations for metastatic melanoma with high tumor burden, highlighting the preference for immune checkpoint combinations like nivolumab with relatlimab for durable ...

Based on durable response data, TAR-200 has been given priority review for the treatment of patients with high-risk ...